Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
This Quarter Return
-16.81%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$29.9B
AUM Growth
+$29.9B
(-21%)
Cap. Flow
+$117M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
25.19%
Holding
1,731
New
72
Increased
561
Reduced
513
Closed
110
Top Buys
| 1 |
ServiceNow
NOW
|
$83.3M |
| 2 |
Amazon
AMZN
|
$68.2M |
| 3 |
Honeywell
HON
|
$66.5M |
| 4 |
EPAM Systems
EPAM
|
$60.2M |
| 5 |
JPMorgan Chase
JPM
|
$54.7M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$70M |
| 2 |
Illinois Tool Works
ITW
|
$61.4M |
| 3 |
Cognizant
CTSH
|
$60.2M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$46.1M |
| 5 |
Wells Fargo
WFC
|
$44.2M |
Sector Composition
| 1 | Technology | 22.3% |
| 2 | Healthcare | 17.72% |
| 3 | Financials | 13.3% |
| 4 | Consumer Discretionary | 9.91% |
| 5 | Industrials | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Amicus Therapeutics
FOLD
$2.34B
| $56K | ﹤0.01% | 6,088 -7,089 | -54% | -$65.2K |
|
1602
ICL Group
ICL
$8.31B
| $55K | ﹤0.01% | 16,865 | – | – |
|
1603
Graphic Packaging
GPK
$6.6B
| $54K | ﹤0.01% | +4,400 | New | +$54K |
|
1604
Resources Connection
RGP
$170M
| $52K | ﹤0.01% | +4,700 | New | +$52K |
|
1605
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$54.4B
| $44K | ﹤0.01% | 500 | – | – |
|
|
OTIC
1606
DELISTED
Otonomy, Inc.
OTIC
| $44K | ﹤0.01% | +22,427 | New | +$44K |
|
1607
Sangamo Therapeutics
SGMO
$157M
| $42K | ﹤0.01% | 6,658 -7,658 | -53% | -$48.3K |
|
1608
DXP Enterprises
DXPE
$1.96B
| $40K | ﹤0.01% | 3,300 +800 | +32% | +$9.7K |
|
1609
Elbit Systems
ESLT
$22.3B
| $40K | ﹤0.01% | 300 | – | – |
|
1610
Ovintiv
OVV
$10.8B
| $37K | ﹤0.01% | 12,387 -49,551 | -80% | -$148K |
|
1611
KalVista Pharmaceuticals
KALV
$678M
| $33K | ﹤0.01% | 4,253 -4,253 | -50% | -$33K |
|
1612
Methanex
MEOH
$2.75B
| $33K | ﹤0.01% | 2,479 | – | – |
|
1613
Spok Holdings
SPOK
$374M
| $33K | ﹤0.01% | +3,100 | New | +$33K |
|
1614
HCI Group
HCI
$2.16B
| $32K | ﹤0.01% | +800 | New | +$32K |
|
1615
Owens & Minor
OMI
$378M
| $29K | ﹤0.01% | +3,200 | New | +$29K |
|
1616
Mirum Pharmaceuticals
MIRM
$3.71B
| $26K | ﹤0.01% | 1,853 -2,853 | -61% | -$40K |
|
1617
Black Diamond Therapeutics
BDTX
$157M
| $25K | ﹤0.01% | +1,000 | New | +$25K |
|
1618
Crinetics Pharmaceuticals
CRNX
$2.92B
| $16K | ﹤0.01% | 1,104 -1,104 | -50% | -$16K |
|
|
ENBL
1619
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $13K | ﹤0.01% | +5,089 | New | +$13K |
|
1620
Caleres
CAL
$507M
| $10K | ﹤0.01% | 1,894 -44,402 | -96% | -$234K |
|
1621
AppFolio
APPF
$9.94B
| – | – | -2,480 | Closed | -$273K |
|
1622
Ares Capital
ARCC
$15.8B
| – | – | -19,121 | Closed | -$357K |
|
1623
Archrock
AROC
$4.35B
| – | – | -128,900 | Closed | -$1.29M |
|
1624
Alcoa
AA
$8.33B
| – | – | -17,029 | Closed | -$366K |
|
1625
Antero Midstream
AM
$8.51B
| – | – | -55,385 | Closed | -$420K |
|